Related Experiment Video

Updated: Jun 25, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

beta-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways

M Zhao1, G Zhou, Y Zhang

  • 1Department of Internal Medicine, James Quillen College of Medicine, East Tennessee State University, TN, USA.

Neoplasma
|February 26, 2009
PubMed
Abstract

Insights

Beta-arrestin2 inhibits morphine-induced cell death in breast cancer cells by regulating Akt and caspase-8 pathways. Targeting beta-arrestin2 may help manage opioid side effects in cancer patients.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Beta-arrestins regulate G-protein-coupled receptors, including opioid receptors.
  • Beta-arrestin2 shows potential in inhibiting cell death.
  • Opioids like morphine can induce cell death, relevant to cancer patient treatment.

Purpose of the Study:

  • To investigate the role of beta-arrestin2 in morphine-induced cell death in breast cancer cells.
  • To elucidate the molecular mechanisms underlying beta-arrestin2's effect on opioid-induced cell death.

Main Methods:

  • Utilized human breast cancer cell lines (MCF-7 and MDA-MB-231).
  • Employed RNA interference (RNAi) to suppress beta-arrestin2 expression.
  • Assessed cell death, phosphorylated Akt levels, and cleaved caspase-8 levels.

Main Results:

  • Beta-arrestin2 significantly blocked morphine-induced cell death in breast cancer cells.
  • Suppression of beta-arrestin2 and morphine treatment attenuated phosphorylated Akt levels.
  • Inhibition of beta-arrestin2 enhanced cleaved caspase-8 levels, indicating caspase-8 involvement.

Conclusions:

  • Beta-arrestin2 blocks morphine-induced cell death via anti-apoptotic Akt and pro-apoptotic caspase-8 pathways.
  • Targeting beta-arrestin2 could be a strategy for managing opioid-related side effects in cancer patients.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...